Scinai Immunotherapeutics Ltd.
SCNI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001611747
No open-market purchases or sales by Scinai Immunotherapeutics Ltd. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $49.1K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Scinai Immunotherapeutics Ltd. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 0 | 10 | +10 |
| Shares | 0 | 242.0K | +242.0K |
| Value | $0 | $716.9K | +$716.9K |
New holders (10)
Institutions that held Scinai Immunotherapeutics Ltd. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 220,562 | $652.9K | 1.75% |
| Citadel Advisors LLC | 17,459 | $51.9K | 0.00% |
| Morgan Stanley | 2,818 | $8.34K | 0.00% |
| Credit Agricole S A | 424 | $1.25K | 0.00% |
| Royal Bank of Canada | 254 | $1.00K | 0.00% |
| UBS Group AG | 300 | $888 | 0.00% |
| Aspire Private Capital, LLC | 160 | $474 | 0.00% |
| Global Retirement Partners, LLC | 50 | $148 | 0.00% |
| Wells Fargo & Company | 20 | $59 | 0.00% |
| NewSquare Capital LLC | 2 | $6 | 0.00% |
Sold out (0)
Institutions that held Scinai Immunotherapeutics Ltd. at the end of Q3 2022 and filed for Q4 2022 without it.
None.